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doi:10.1Objectives: Despite a trend toward sublobar resections for lung cancers, some question the adequacy of limited
resections in the treatment of lung cancer and questions remain about performing these procedures by video-
assisted thoracoscopic surgery (VATS). We compared the survival for lung cancers treated with VATS segmen-
tectomy versus VATS lobectomy.
Methods: VATS segmentectomy and lobectomy for both malignant and benign lung pathology are reviewed
from a single institution.
Results: Between 1998 and 2010, 73 VATS trisegmentectomies were performed in 49 women and 24 men
(mean age, 72 years). Diagnoses included primary lung cancer (91%), benign disease (4%), and metastatic
disease (5%). Primary lung cancers were 68% for stage IA, 17% for stage IB, and 15% for stage II-IV. Se-
venty-three left upper lobe (LUL) trisegmentectomies were performed. Mean hospital stay after VATS triseg-
mentectomy was 3.8 days, versus 5.5 days after VATS LUL lobectomy (P ¼ .0736). Complication rates for
trisegmentectomy group (37%) and lobectomy (17%; P>.05) were not statistically different. Survival after
VATS trisegmentectomy and LUL lobectomy for either stage IA lung cancer or stage IB lung cancer was not
statistically significant.
Conclusions: Segmentectomy can be performed by VATS with no greater morbidity and mortality than with
VATS lobectomy. LUL trisegmentectomy provides the same survival as lobectomy for stage IA and IB tumors.
Our experience supports the use of lingular-sparing trisegmentectomy in the treatment of stage IA and IB lung
cancer. (J Thorac Cardiovasc Surg 2012;144:S23-6)Anatomic lung resection for lung cancer has traditionally
involved lobectomy and node dissection.1 The shift to this
lesser resection was a natural progression from pneumonec-
tomy, the previous criterion standard for the treatment of
lung cancer. As this desire to perform lesser resections
while maintaining oncologic principles continues to evolve,
surgeons have probed into the use of anatomic segmental re-
sections for small lung cancers (<2 cm)2,3; however, most
of these studies have looked at node-negative tumors of
stage IA.4-6
Additionally, there are newer options to the surgical ap-
proach in the performance of anatomic segmentectomy.
Video-assisted thoracoscopic surgery (VATS) has presented
itself as an alternative approach to the open technique.
VATS has been demonstrated to be associated with shortere Division of Thoracic Surgery, Cedars-Sinai Medical Center, Los Angeles,
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The Journal of Thoracic and Castay, faster recovery, and greater ability for the patient to tol-
erate adjuvant therapy, thus allowing more complete deliv-
ery of adjuvant therapy.7,8
The literature is not as robust when it comes to stage IB
tumors.9 Some have postulated that increasing the amount
of lung parenchyma taken and thus extending the surgical
margins could overcome the increased recurrence risk im-
posed by the larger tumor size.9,10
There remain questions regarding the applicability of
segmentectomy in patients with lung cancer. In this
article we review our experience with the largest single-
institution series of VATS anatomic segmentectomy and
VATS lobectomies to date and evaluate hospital stay as
well as cancer outcomes.MATERIALS AND METHODS
Patients
Approval for this study was provided by the institutional review board of
Cedars-Sinai Medical Center (approval 4267). A retrospective review of
a prospectively gathered data base was performed. We identified 149 con-
secutive VATS segmentectomies performed at our institution from 1998 to
2010. Diagnoses included primary lung cancer, benign disease, and meta-
static disease. The primary lung cancers included stage IA, stage IB, and
stage II and greater.
We compared the results of 73 VATS trisegmentectomies for stage IA
(n ¼ 45) and IB (n ¼ 11) lung cancer at our institution with 266 VATS left
upper lobe (LUL) lobectomies for stage IA (n ¼ 105) and IB (n ¼ 73)
lung cancer performed during the same period at our institution.rdiovascular Surgery c Volume 144, Number 3 S23
TABLE 1. Comparison of the complications for trisegmentectomies
and left upper lobectomies
Complications
Trisegmentectomy
Left upper
lobectomy
n % n %
Air leak 10 13.7 13 4.9
Atrial fibrillation 6 8.2 9 3.4
Urinary retention 2 2.7 0 0
Perioperative mortality 1 1.4 2 0.8
Pneumonia 1 1.4 2 0.8
Subcutaneous emphysema 1 1.4 2 0.8
Conversion to thoracotomy 1 1.4 0 0
Recurrent laryngeal nerve damage 1 1.4 0 0
Pain 1 1.4 0 0
Wound infection 1 1.4 0 0
Syncope 1 1.4 0 0
Bradycardia 1 1.4 0 0
Bleeding 0 0 3 1.1
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Under single-lung anesthesia, the VATS lobectomies and segmentecto-
mies were anatomic dissections with individual ligation of the vessels and
bronchi. A 5-mm trocar for the 5-mm, 30 thoracoscope was placed
through the 8th intercostal space in the midaxillary line. A 2-cm incision
was made in the 6th intercostal space in the midclavicular line. A utility in-
cision was made directly lateral from the vein for upper and middle lobec-
tomies, or 1 intercostal space lower for lower lobectomies. This incision
started on the anterior border of the latissimus muscle and extended ante-
riorly for 4 to 6 cm. In some cases, another 1-cm incision was made in the
auscultatory triangle.11 Lymph nodes were either sampled or dissected.
Statistical Analysis
Segmentectomy and lobectomy cohorts were compared with respect to
clinical, pathologic, and demographic findings. The Student t test was used
to compare morbidity rates and stays, and c2 tests were used to calculate
probability distributions (P values). Kaplan-Meier survival curves with
log-rank test were used to compare survival distributions between the seg-
mentectomy and lobectomy arms and to detect trends in survival, and the
associated P value. Values are mean  SD.
Readmission 0 0 4 1.5
Empyema 0 0 1 0.4
Bronchopleural fistula 0 0 1 0.4
Atelectasis 0 0 1 0.4
Urinary tract infection 0 0 1 0.4
Myocardial infarction 0 0 2 0.8
Pneumothorax 0 0 1 0.4
Cerebrovascular accident 0 0 1 0.4
Splenic injury 0 0 1 0.4
None 46 63 222 83.5
Total 73 100 266 100.0
Complication rate 27 37 44 17
For comparison of overall complication rate, P>.05.RESULTS
The average age of patients treated with trisegmentec-
tomy was 72 years. Sex distribution was 49 female and 24
male patients.
Mean hospital stay for patients undergoing VATS triseg-
mentectomy was 3.8  3.3 days, versus 5.5  7.9 days for
VATS LUL lobectomy (P ¼ .0736).
Seventy-three LUL trisegmentectomies were performed.
Diagnoses for the trisegmentectomies included primary
lung cancer (91%; 66/73), benign disease (4%; 3/73),
and metastatic disease (5%; 4/73). Of the VATS trisegmen-
tectomies for primary lung cancers, 68% (45/66) were for
stage IA disease, 17% (11/66) were for stage IB disease,
and 15% (10/66) were for stage II and greater disease.
In the trisegmentectomy group, the complication rate was
37% (n ¼ 27), versus 17% (n ¼ 44) for VATS LUL lobec-
tomy (P>.05).There was no statistical difference in overall
complication rate between the groups (Table 1).Survival
There was no difference in survival between patients un-
dergoing VATS trisegmentectomy and those undergoing
LUL lobectomy for either stage IA lung cancer or stage
IB lung cancer (Figures 1-3).FIGURE 1. The Kaplan-Meier curves compare the overall survivals for
patients who underwent trisegmentectomy (TRISEG) and left upper lobec-
tomy (LUL LOBE). There is no difference in overall survival between the
patient populations.DISCUSSION
There is a long history of segmentectomy for pulmonary
disease. Churchill and Belsey12 reported performing a seg-
mentectomy for bronchiectasis in 1939, and Jensik and col-
leagues13 reported a 15-year experience of segmentectomy
for lung cancer in 1973. In the 1980s, the Lung Cancer
Study Group demonstrated a 20% better survival for pa-
tients who underwent a lobectomy rather than a sublobar re-
section.1,14 Because of this disparity, lobectomy has been
adopted as the criterion standard and is the most commonS24 The Journal of Thoracic and Cardiovascular Surgoption in the surgical treatment of lung cancer. Lesser
resections are being revisited, however, as a result of
screening and earlier diagnosis, with the finding of
smaller and earlier lung tumors. Beginning in the 1990s,
reports have suggested that anatomic segmentectomy may
result in survival as good as that of lobectomy in theery c September 2012
FIGURE 2. The Kaplan-Meier curves compare the overall survivals for
patients who underwent trisegmentectomy (TRISEG) and left upper lobec-
tomy (LUL LOBE) for stage IA lung cancer. There is no difference in sur-
vival between trisegmentectomy and left upper lobectomy for stage IA.
NSCLC; Non–small cell lung cancer.
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results.18 Additionally, Watanabe and coworkers19 showed
that a node dissection by VATS is as good as the node dis-
section performed by thoracotomy.
Minimally invasive (VATS) lobectomy is now well estab-
lished. Relative to a thoracotomy, a VATS approach to lo-
bectomy has been shown to provide reduced morbidity
and mortality,20-22 shorter stay,23 less pain,24 earlier recov-
ery,24,25 lower cost,26 better pulmonary function,27 less im-
pact on the immune system,28 and a better chance of
receiving planned adjuvant chemotherapy.29 The significant
benefits for VATS were summarized nicely in a meta-
analysis by Cheng and colleagues.30
With the benefit of lobectomy by VATS compared to tho-
racotomy firmly established, the question remains, what
about VATS segmentectomy?FIGURE 3. The Kaplan-Meier curves compare the overall survivals for
patients who underwent trisegmentectomy (TRISEG) and left upper lobec-
tomy (LUL LOBE) for stage IB lung cancer. There is no difference in sur-
vival between trisegmentectomy and left upper lobectomy for stage IB.
NSCLC; Non–small cell lung cancer.
The Journal of Thoracic and CaA few small series of VATS segmentectomies have been
reported.31-33 When comparing 48 VATS and 29 open
segmentectomies, Atkins and coworkers31 found no differ-
ence in morbidity, but hospital stay (mean, 4.3 vs 6.8 days)
and mortality (0% vs 6.9%) favored VATS. When compar-
ing 104 VATS and 121 open segmentectomies, Schuchert
and colleagues32 found no difference in morbidity and mor-
tality, but hospital stay favored VATS (median, 5 vs 7 days).
How does VATS segmentectomy compare with VATS
lobectomy? In our series, VATS segmentectomy compares
favorably with VATS lobectomy.
The biggest concern for a cancer operation is survival
rates. In our series, the overall survival was the same for
the segmentectomies and the lobectomies. That survival
can be affected by many factors, including staging and
comorbidities. The comparison of segmentectomy versus
lobectomy was most illuminating for LUL cancers. The
survival related to the treatment of stage IA and IB tumors
was just as good for segmentectomy as for lobectomy.
Our findings are consistent with other published
literature. In a comparison of lobectomy with sublobar
resection, Warren34 showed better survival with lobectomy.
There was a significantly higher local recurrence rates for
sublobar resections, especially for tumors larger than 3
cm (T2 tumors). In a comparison of VATS segmentectomy
versus open segmentectomy, Atkins and coworkers31 found
a significantly better survival for VATS; however, the mean
tumor size in the VATS cases was 2.1 cm, versus 3.1 cm in
the open cases. This is consistent with the difference in sur-
vival by stage, rather than any difference in VATS versus
open surgery.
In summary, segmentectomy can be performed by VATS
with no more morbidity or mortality than that seen with
VATS lobectomy. Transecting parenchyma for the segmen-
tectomy does not translate into a longer stay than after lo-
bectomy. The lingular need not be resected for small
apical lung cancers, because LUL trisegmentectomy pro-
vides the same survival as lobectomy for stage IA and IB
tumors. Our experience supports the use of lingular-sparing
trisegmentectomy in the treatment of IA and IB lung cancer.References
1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited re-
section for T1 N0 non–small cell lung cancer. Lung Cancer Study Group. Ann
Thorac Surg. 1995;60:615-23.
2. Schuchert MJ, Pettiford BL, Keeley S, D’Amato TA, Kilic A, Close J, et al. An-
atomic segmentectomy in the treatment of stage I non–small cell lung cancer.
Ann Thorac Surg. 2007;84:926-33.
3. Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical
sublobar resection for small-sized non–small cell lung cancer: a multicenter
study. J Thorac Cardiovasc Surg. 2006;132:769-75.
4. Tsubota N, Ayabe K, Doi O, Mori T, Namikawa S, Taki T, et al. Ongoing pro-
spective study of segmentectomy for small lung tumors. Ann Thorac Surg.
1998;66:1787-90.
5. Nonaka M, Kadokura M, Yamamato S, Kataoka D, Kunimura T, Kushima M,
et al. Tumor dimension and prognosis in surgically treated lung cancer: for inten-
tional limited resection. Am J Clin Oncol. 2003;26:499-503.rdiovascular Surgery c Volume 144, Number 3 S25
Session II: Lung Cancer Treatment Soukiasian et al6. Koike T, Yamato Y, Yoshiya K, Shimoyama T, Suzuki R. Intentional limited pul-
monary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac
Cardiovasc Surg. 2003;125:924-8.
7. Nicastri DG, Wisnivesky JP, Litle VR, Yun J, Chin C, Dembitzer FR, et al. Thor-
acoscopic lobectomy: report on safety, discharge independence, pain, and che-
motherapy tolerance. J Thorac Cardiovasc Surg. 2008;135:642-7.
8. Petersen RP, Pham D, BurfeindWR, Hanish SI, Toloza EM, Harpole DH Jr, et al.
Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection
for lung cancer. Ann Thorac Surg. 2007;83:1245-50.
9. Birdas TJ, Koehler RP, Colonias A, Trombetta M, Maley RH Jr, Landreneau RJ,
et al. Sublobar resection with brachytherapy versus lobectomy for stage IB non-
small cell lung cancer. Ann Thorac Surg. 2006;81:434-9.
10. Yoshikawa K, Tsubota N, Kodama K, Ayabe H, Taki T, Mori T. Prospective study
of extended segmentectomy for small lung tumors: the final report. Ann Thorac
Surg. 2002;73:1055-9.
11. McKenna RJ Jr. VATS lobectomy with mediastinal lymph node sampling or dis-
section. Chest Surg Clin North Am. 1995;4:223-32.
12. Churchill ED, Belsey R. Segmental pneumonectomy in bronchiectasis. Ann Surg.
1939;109:481-99.
13. Jensik RJ, Faber LP, Milloy FJ, Monson DO. Segmental resection for lung
cancer: a fifteen-year experience. J Thorac Cardiovasc Surg. 1973;63:
563-72.
14. Kittle CF, Faber LP, Jensik RJ,WarrenWH. Pulmonary resection in patients after
pneumonectomy. Ann Thorac Surg. 1985;40:294-9.
15. KodamaK, Doi O, HigashiyamaM, Yokouchi H. Intentional limited resection for
selected patients with T1 N0 M0 non–small cell lung cancer: a single-institution
study. J Thorac Cardiovasc Surg. 1997;114:347-53.
16. Martin-Ucar AE, Nakas A, Pilling JE, West KJ, Waller DA. A case-matched
study of anatomical segmentectomy versus lobectomy for stage I lung cancer
in high-risk patients. Eur J Cardiothorac Surg. 2005;27:675-9.
17. Okada M, Yoshikawa K, Hatta T, Tsubota N. Is segmentectomy with lymph node
assessment an alternative to lobectomy for non–small cell lung cancer of 2 cm or
smaller? Ann Thorac Surg. 2001;71:956-61.
18. Harada H, OkadaM, Sakamoto T, Matsuoka H, Tsubota N. Functional advantage
after radical segmentectomy versus lobectomy for lung cancer. Ann Thorac Surg.
2005;80:2041-5.
19. WatanabeA,Koyanagi T,OhsawaH,Mawatari T,NakashimaS, TakahashiN, et al.
Systematic nodedissectionbyVATS isnot inferior to throughanopen thoracotomy:
a comparative clinicopathologic retrospective study. Surgery. 2005;138:510-7.
20. McKenna RJ Jr, Houck W, Fuller CB. Video-assisted thoracic surgery lobec-
tomy: experience with 1,100 cases. Ann Thorac Surg. 2006;81:421-6.S26 The Journal of Thoracic and Cardiovascular Surg21. Hoksch B, Ablassmaier B,WalterM,M€uller JM. [Complication rate after thoraco-
scopic and conventional lobectomy]. Zentralbl Chir. 2003;128:106-10. German.
22. Onaitis MW, Petersen RP, Balderson SS, Toloza E, BurfeindWR, Harpole DH Jr,
et al. Thoracoscopic lobectomy is a safe and versatile procedure: experience with
500 consecutive patients. Ann Surg. 2006;244:420-5.
23. Swanson SJ, Herndon JE 2nd, D’Amico T, Demmy T, McKenna RJ Jr, et al.
Video-assisted thoracic surgery lobectomy: report of CALGB 39802—a prospec-
tive, multi-institution feasibility study. J Clin Onco. 2007;25:4993-7.
24. Demmy TL, Curtis JJ. Minimally invasive lobectomy directed toward frail
and high-risk patients: a case-control study. Ann Thorac Surg. 1999;68:
194-200.
25. McVay CL, Fuller CB, Houck W, McKenna R Jr. VATS anatomic pulmonary re-
section in octogenarians. Am Surg. 2005;71:791-3.
26. Nakajima J, Takamoto S, Kohno T, Ohtsuka T. Costs of videothoracoscopic sur-
gery versus open resection for patients with of lung carcinoma. Cancer. 2000;
89(11 Suppl):2497-501.
27. Nakata M, Saeki H, Yokoyama N, Kurita A, Takiyama W, Takashima S. Pulmo-
nary function after lobectomy: video-assisted thoracic surgery versus thoracot-
omy. Ann Thorac Surg. 2000;70:938-41.
28. Walker WS, Leaver HA. Immunologic and stress responses following video-
assisted thoracic surgery and open pulmonary lobectomy in early stage lung can-
cer. Thorac Surg Clin. 2007;17:241-9. ix.
29. Flores RM, Rusch VW. Video-assisted thoracic surgery. In: Wilmore DW,
Cheung LY, Harken AH, Holcroft JW, Meakins JL, Soper NJ, eds. ACS Surgery:
Principles and Practice. New York, NY: Web MD, Inc; 2003.
30. Cheng D, Downey RJ, Kernstine K, Stanbridge R, Shennib H, Wolf R, et al.
Video-assisted thoracic surgery in lung cancer resection: a meta-analysis and sys-
tematic review of controlled trials. Innovations (Phila). 2007;2:261-92.
31. Atkins BZ, Harpole DH Jr, Mangum JH, Toloza EM, D’Amico TA,
Burfeind WR Jr. Pulmonary segmentectomy or thoracotomy or thoracoscopy: re-
duced hospital length of stay with a minimally invasive approach. Ann Thorac
Surg. 2007;84:1107-13.
32. Schuchert MJ, Pettiford BL, Pennathur A, Abbas G, Awais O, Close J, et al. An-
atomic segmentectomy for stage I non–small cell lung cancer: comparison of
video-assisted thoracic surgery versus open approach. J Thorac Cardiovasc
Surg. 2009;138:1318-25.e1.
33. Ohtsuka T, Nomori H, Horio H, Naruke T, Suemasu K. Is major pulmonary re-
section by video-assisted thoracic surgery an adequate procedure in clinical stage
I lung cancer? Chest. 2004;125:1742-6.
34. Warren W, Faber P. Segmentectomy versus lobectomy in patients with stage I
pulmonary carcinoma. J Thorac Cardiovasc Surg. 1994;107:1087-94.ery c September 2012
